Ken Griffin Conmed Corp Call Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$61.9 - $80.36 $742,800 - $964,320	-12,000 Reduced 68.97%	5,400 $374,000
Q1 2024 May 15, 2024	SELL	$75.36 - $112.51 $1.34 Million - $2 Million	-17,800 Reduced 50.57%	17,400 $1.39 Million
Q4 2023 Feb 14, 2024	BUY	$91.3 - $115.05 $575,190 - $724,815	6,300 Added 21.8%	35,200 $3.85 Million
Q3 2023 Nov 14, 2023	SELL	$97.55 - $135.91 $87,795 - $122,319	-900 Reduced 3.02%	28,900 $2.91 Million
Q2 2023 Aug 14, 2023	BUY	$102.55 - $136.38 $276,885 - $368,226	2,700 Added 9.96%	29,800 $4.05 Million
Q1 2023 May 15, 2023	SELL	$89.75 - $107.27 $2.98 Million - $3.56 Million	-33,200 Reduced 55.06%	27,100 $2.81 Million
Q4 2022 Feb 14, 2023	BUY	$72.84 - $94.04 $3.52 Million - $4.54 Million	48,300 Added 402.5%	60,300 $5.34 Million
Q3 2022 Nov 14, 2022	BUY	$77.78 - $103.92 $738,910 - $987,240	9,500 Added 380.0%	12,000 $962,000

314

35.5M

122K

29.9K

Ticker CNMD
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 30,482,400
Market Cap $2.28B
Description
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.